Welcome to our dedicated page for Loomis A B news (Ticker: LOIMY), a resource for investors and traders seeking the latest updates and insights on Loomis A B stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Loomis A B's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Loomis A B's position in the market.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
The shareholders of Loomis (OTC-PINK:LOIMY) are invited to the annual general meeting (AGM) scheduled for May 4, 2023, at 5 p.m. CEST in Stockholm. Shareholders must be listed in the share register as of April 25, 2023 and notify Loomis of attendance by April 27, 2023. The AGM agenda includes the election of board members, consideration of a dividend of SEK 12 per share with a record date of May 8, 2023, and the introduction of a long-term incentive program (LTIP 2023) aimed at aligning management's interests with shareholders. The total remuneration for board members is proposed at SEK 5,300,000.